Atopic Dermatitis: What's Best Treatment Practice?

Conference|Maui Derm NP+PA Summer

Eric Simpson, MD, MCR, director of clinical research and dermatology professor at the Frances J. Storrs medical school at Oregon Health & Science University in Portland, Oregon, explains dives into what 2022 is bringing to the AD space.

Related Videos
Related Content

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023
© 2023 MJH Life Sciences

All rights reserved.